Tasmar and hepatic enzyme increased Patient Reports February 13, 2012

Tasmar Side Effects Report #5281224-0
Tasmar side effect was reported by a Physician from GERMANY on Mar 06, 2007. Male patient, 80 years of age, was diagnosed with parkinsonism and was treated with Tasmar. After drug was administered, patient experienced the following side effects: anaemia, blood creatine phosphokinase increased, compartment syndrome, deep vein thrombosis , hepatic enzyme increased, multi-organ failure, myocardial infarction. Tasmar dosage: unknown. During the same period patient was treated with ISOCOM, SIFROL, TRAZODONE, SEROQUEL, AMANTADINE. Patient was hospitalized. Patient died on 01/27/2007.

Tasmar Side Effects Report #5270422-8
Tasmar side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 26, 2007. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, fall , hepatic enzyme increased, influenza, nausea , parkinson's disease . Tasmar dosage: 100 MG; TID; PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.

Tasmar Side Effects Report #5154553-9
Tasmar side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 30, 2006. Female patient, 68 years of age, weighting 117.9 lb, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood alkaline phosphatase increased, condition aggravated, fall , hepatic enzyme increased, hepatic failure, influenza, malaise, parkinson's disease . Tasmar dosage: 100 MG TID PO. During the same period patient was treated with PROPRANOLOL, DOMPERIDONE, CARBIDOPA. Patient recovered.

Tasmar Side Effects Report #4838065-5
Tasmar side effect was reported by a Physician from SWITZERLAND on Feb 18, 2004. Male patient, 61 years of age, weighting 159.8 lb, was diagnosed with parkinson's disease , sedation, anaesthesia, intubation, mean arterial pressure and was treated with Tasmar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, blood pressure decreased, cardiac failure acute, haemoglobin decreased, hepatic enzyme increased, hyperhidrosis, liver disorder, lung disorder, metabolic acidosis. Tasmar dosage: unknown. During the same period patient was treated with MADOPAR, LORAZEPAM, THIOPENTAL, PANCURONIUM, ISOFLURANE, FENTANYL, NOREPINEPHRINE, ACETAMINOPHEN. Patient died on 09/04/2000.


Tasmar Side Effects Report #4621109-3
Tasmar side effect was reported by a Physician from on Feb 15, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, hepatic enzyme increased. Tasmar dosage: 100 MG; 3 TIMES A DAY; ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE DULFATE, NACOM, PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE SULPHATE, COMITESS. Patient was hospitalized. Patient recovered.

Tasmar Side Effects Report #4639099-6
Tasmar side effect was reported by a Physician from on Apr 08, 2005. Male patient, 60 years of age, was diagnosed with parkinson's disease  and was treated with Tasmar. After drug was administered, patient experienced the following side effects: aortic valve sclerosis, bronchitis acute, hepatic enzyme increased. Tasmar dosage: 100 MG; 3 TIMES A DAY; ORAL; SEE IMAGE. During the same period patient was treated with PERGOLIDE MESYLATE, CARBIDOPA AND LEVODOPA, AMANTADINE SULPHATE, COMTESS, NACOM. Patient was hospitalized. Patient recovered.